|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/519 | (2006.01) |
| A61P 9/12 | (2006.01) | ||
| A61P 11/00 | (2006.01) |
| (11) | Patento numeris | 3437644 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17774891.0 |
| Europos patento paraiškos padavimo data | 2017-03-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-02-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-06-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2017/012305 |
| Data | 2017-03-27 |
| (87) | Numeris | WO 2017/170354 |
| Data | 2017-10-05 |
| (30) | Numeris | Data | Šalis |
| 2016063747 | 2016-03-28 | JP |
| (72) |
KATO, Juran , JP
YAMAKAWA, Hiroko , JP
MURAKI, You , JP
MAHANANDEESHWAR, Gattu , IN
SATYALAKSHMI, Oruganty , IN
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome,
Chuo-ku,
Osaka-shi,, Osaka 541-0045,
JP
|
| (54) | COMPOUNDS FOR USE IN THE TREATMENT OF PULMONARY HYPERTENSION |
| COMPOUNDS FOR USE IN THE TREATMENT OF PULMONARY HYPERTENSION |